Cargando…
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer
Multidrug resistance (MDR) is considered as a primary hindrance for paclitaxel failure in non-small cell lung cancer (NSCLC) patients, in which P-glycoprotein (P-gp) is overexpressed and the PI3K/Akt signaling pathway is dysregulated. Previously, we designed and synthesized DHW-221, a dual PI3K/mTOR...
Autores principales: | Liu, Mingyue, Xu, Chang, Qin, Xiaochun, Liu, Wenwu, Li, Deping, Jia, Hui, Gao, Xudong, Wu, Yuting, Wu, Qiong, Xu, Xiangbo, Xing, Bo, Jiang, Xiaowen, Lu, Hongyuan, Zhang, Yingshi, Ding, Huaiwei, Zhao, Qingchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137409/ https://www.ncbi.nlm.nih.gov/pubmed/35646704 http://dx.doi.org/10.3389/fonc.2022.873649 |
Ejemplares similares
-
Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer
por: Qin, Xiaochun, et al.
Publicado: (2021) -
A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway
por: Wang, Shu, et al.
Publicado: (2020) -
DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis
por: Wang, Shu, et al.
Publicado: (2022) -
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway
por: Qin, Xiaochun, et al.
Publicado: (2022) -
Potential Savings in DHW Facilities through the Use of Solar Thermal Energy in the Hospitals of Extremadura (Spain)
por: Sánchez-Barroso, Gonzalo, et al.
Publicado: (2020)